Etravirine Tablet shortage
To Be Discontinued 2 presentations · 1 manufacturers · first FDA posting 2026-04-28 · last update 2026-04-28
Manufacturers: Janssen Research and Development
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Etravirine, Tablet, 100 mg (NDC 10147-0570-1) | Janssen Research and Development | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/28/2026 Updated 04/28/2026 Discontinued 04/28/2026 |
| Intelence, Tablet, 100 mg (NDC 59676-570-01) | Janssen Research and Development | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 04/28/2026 Updated 04/28/2026 Discontinued 04/28/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)